FISH Beats Molecular Karyotyping

We would like to comment on John Ashkenas' recent article on molecular karyotyping in the Jan. 17, 2005, issue of The Scientist.1 We attended the American Society of Human Genetics meeting as well and came away with a different impression of molecular karyotyping. While this technique will eventually and undoubtedly reveal new insights into human genome structure and copy-number variation, the data are still quite noisy and often unconvincing. Indeed, this copy-number variation is probably the s

Written byPeter Rogan
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

We would like to comment on John Ashkenas' recent article on molecular karyotyping in the Jan. 17, 2005, issue of The Scientist.1 We attended the American Society of Human Genetics meeting as well and came away with a different impression of molecular karyotyping. While this technique will eventually and undoubtedly reveal new insights into human genome structure and copy-number variation, the data are still quite noisy and often unconvincing. Indeed, this copy-number variation is probably the source of much of the noise, as well as variability in the quality of C0 t1 DNA used to quench repetitive sequence hybridization.2These factors contribute to difficulties in unequivocal interpretation of array comparative genomic hybridization results.

Conventional FISH [fluorescence in situ hybridization], on the other hand, provides a context-dependent measurement of copy number that can unequivocally identify balanced chromosome rearrangements (this is a challenge for molecular karyotyping, especially for detection of balanced intrachromosomal rearrangements). ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies